Overview

Initial Versus Delayed PDT Combination With Conbercept in PCV

Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
To compare the initial versus delayed verteporfin photodynamic therapy (PDT) in combination with conbercept in patients with symptomatic polypoidal choroidal vasculopathy (PCV).
Phase:
Phase 4
Details
Lead Sponsor:
The Eye Hospital of Wenzhou Medical University
Treatments:
Verteporfin